do glp 1 cause kidney damage Frontiers Glucagon-like peptide-1 receptor signaling modifies

Table 1 presents the demographic and clinical characteristics of the reported cases, stratified by gender distribution, age groups, body weight categories, reporter profiles, geographical origin, and clinical outcomes

Innate immunity in diabetic kidney disease

doi: 10.1002/oby.23673, 71

Originally developed for obesity treatment, it stimulates fat breakdown and inhibits fat accumulation, making it a powerful tool for fat loss and body composition improvement

Power calculations suggest that previous studies would have had limited power to detect an effect size similar to that identified in our study (Supplementary Table 23), and also differed in terms of drug type, disease cohort and analytical choices